Products for Research Use Only
RegisterLogin

CB-103

CAT: 0013-GTR19156821-01Size: 1 gDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19156821-01Size:1 g
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CB-103 is a orally active inhibitor of notch signaling pathway, with anti-tumor activity. CB-103 has shown the ability to block NOTCH signaling in human T cell acute lymphoblastic leukemia cancer cell lines, and exhibits anti-tumor efficacy in GSI resistant T-ALL cell lines.CB-103 inhibits growth of GSI/Mab resistant triple negative breast cancer, and exhibits anti-tumor activity in xenograft models of human T-ALL and mouse mammary tumors. (In Vitro) :CB-103 acts as a pan-NOTCH inhibitor by targeting NOTCH transcriptional activation complex.CB-103 can block NOTCH signaling in human T cell acute lymphoblastic leukemia cancer cell lines.CB-103 exhibits anti-tumor efficacy in GSI resistant T-ALL cell lines. (In Vivo) :CB-103 inhibits NOTCH dependent cellular processes in mice.CB-103 blocks in vivo growth of PDX models of T-ALL.CB-103 (25 mg/kg; i.p./p.o.; 2x daily; for 2 weeks) inhibits growth of GSI/Mab resistant triple negative breast cancer.CB-103 exhibits anti-tumor activity in xenograft models of human T-ALL and mouse mammary tumors.
CAS Number
218457-67-1
Purity
>98% (HPLC)
Solubility
DMSO:230 mg/mL (949.16 mM; Need ultrasonic)
Smiles
CC (C) (C) c1ccc (Oc2ccc (N) cn2) cc1
Molecular Formula
C15H18N2O
Molecular Weight
242.32
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.

Chemical Information

Cb-103

CB-103 is an organic molecular entity. It has a role as an inhibitor and an antineoplastic agent.

CAS Number218457-67-1
PubChem CID2735289
IUPAC Name6-(4-tert-butylphenoxy)pyridin-3-amine
Molecular FormulaC15H18N2O
Molecular Weight242.32
XLogP3.7
Topological Polar Surface Area48.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count3
Heavy Atom Count18
Formal Charge0
Complexity254
SMILES
CC(C)(C)C1=CC=C(C=C1)OC2=NC=C(C=C2)N
InChI
InChI=1S/C15H18N2O/c1-15(2,3)11-4-7-13(8-5-11)18-14-9-6-12(16)10-17-14/h4-10H,16H2,1-3H3
InChIKey
WHIWGRCYMQLLAO-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Cb-103
CAS: 218457-67-1
CID: 2735289
Formula: C15H18N2O
MW: 242.32
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight242.32
XLogP33.7
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count3
Exact Mass242.141913202
Monoisotopic Mass242.141913202
Topological Polar Surface Area48.1 Ų
Heavy Atom Count18
Formal Charge0
Complexity254
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
GTR19209552-01CB-64D
GTR19199402-01CB 3717
GTR19195208-01CB 3703
GTR19195207-01CB 3731
GTR19195203-01CB-403
GTR19185282-01CB 168
GTR19240569-01CB-184
GTR19232479-01Psi Cb
GTR19175059-01CB-7921220
GTR19262647-01CB-0821

Alternative Products

CatalogName
B3256-50CB-103
A22160-50CB-103 50mg
S9719-5mgLimantrafin (CB-103)
A22160-100CB-103 100mg
A22160-200Limantrafin (CB-103) 200mg
A22160-10mM-DLimantrafin (CB-103) 10mM * 1mL in DMSO
RSD81788-01CB-6644
HY-101863CB-6673567
HY-128724-01CB-5339

Popular Products